FDA Approves Dupilumab, First and Only Targeted Medicine for Bullous Pemphigoid Dermatology Times Nawigacja wpisu Field-Tested Readiness: Navy Preventive Medicine Proves Expeditionary Capability in the Baltics – DVIDS Threat in your medicine cabinet: The FDA’s gamble on America’s drugs – CNN
